At a glance

At a glance
CSR report
Consolidated Key Figures

(thousands of €, if not stated otherwise)

Year ended 31 December 2020

Year ended 31 December 2019

Year ended 31 December 2018

INCOME STATEMENT (**)

 

 

 

Revenues

478,053

834,901

278,666

Other income

52,207

50,896

29,000

R&D expenditure

(523,667)

(420,090)

(316,222)

S, G&A expenses

(185,225)

(96,959)

(38,523)

Operating expenses

(708,892)

(517,049)

(354,746)

Operating profit/loss (-)

(178,632)

368,748

(47,080)

Net financial results

(131,143)

(220,223)

15,662

Taxes

(1,226)

165

(822)

Net profit/loss (-) from continuing operations

(311,001)

148,689

(32,240)

Net profit from discontinued operations, net of tax

5,565

1,156

2,981

Net profit/loss (-)

(305,436)

149,845

(29,259)

 

 

 

 

BALANCE SHEET

 

 

 

Cash and cash equivalents

2,135,187

1,861,616

1,290,796

Current financial investments

3,026,278

3,919,216

-

R&D incentives receivables

135,728

115,356

84,646

Assets

5,717,731

6,068,609

1,439,496

Shareholders' equity

2,670,355

2,875,658

1,214,249

Deferred income

2,809,133

3,000,646

149,801

Other liabilities

238,242

192,305

75,446

 

 

 

 

CASH FLOW

 

 

 

Operational cash flow/operational cash burn (-) (*)

(517,404)

3,162,809

(158,384)

Cash flow generated/used (-) in operating activities

(427,336)

3,208,617

(142,466)

Cash flow generated/used (-) in investing activities

757,288

(3,764,660)

(15,914)

Cash flow generated in financing activities

22,040

1,335,751

287,876

Increase in cash and cash equivalents

351,994

779,708

129,497

Transfer to current financial investments

-

(198,922)

-

Effect of currency exchange rate fluctuation on cash and cash equivalents

(70,539)

(9,966)

10,089

Cash and cash equivalents on 31 December

2,143,071

1,861,616

1,290,796

 

 

 

 

Cash and cash equivalents from continuing operations

2,135,187

1,861,616

1,290,796

Cash and cash equivalents classified as assets held for sale

7,884

-

-

Current financial investments on 31 December

3,026,278

3,919,216

-

Total current financial investments and cash and cash equivalents on 31 December

5,169,349

5,780,832

1,290,796

 

 

 

 

FINANCIAL RATIOS

 

 

 

Number of shares issued on 31 December

65,411,767

64,666,802

54,465,421

Basic income/loss (-) per share (in €)

(4.69)

2.60

(0.56)

Diluted income/loss (-) per share (in €)

(4.69)

2.49

(0.56)

Share price on 31 December (in €)

80.48

186.50

80.56

Total group employees on 31 December (number) (***)

1,489

1,003

725

(*)

We refer to note 19 of our consolidated financial statements for an explanation and reconciliation of this alternative performance measure.

(**)

The 2019 and 2018 comparatives have been restated to consider the impact of classifying the Fidelta business as discontinued operations in 2020.

(***)

The number of employees at 31 December 2020 includes 185 employees of Fidelta, which has been sold to Selvita on 4 January 2021.

Employees per site

Employees per site (graphic)

Number of employees Galapagos group

Number of employees Galapagos group (bar chart)

Total number of employees includes 185 employees from Fidelta, which was sold to Selvita on 4 January 2021, and includes consultants and temporary staff